Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ED50 and ED95 of Remimazolam Intravenous Bolus on the Loss of Consciousness in Patients Undergoing General Anesthesia

NCT04901871 is registered in ClinicalTrials.gov with Gangnam Severance Hospital as lead sponsor.

NCT NCT04901871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04901871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ED50 and ED95 of Remimazolam Intravenous Bolus on the Loss of Consciousness in Patients Undergoing General Anesthesia
Lead sponsor
Gangnam Severance Hospital
Phase
Phase 3
Overall status
Completed
Start date
May 27, 2021
Completion date
July 26, 2021
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

loss of consciousness